Evaporimeter and Bubble-Imaging Measures of Sweat Gland Secretion Rates
Jeeyeon Kim, Miesha Farahmand, Colleen Dunn, Zoe Davies, Eric Frisbee, Carlos Milla, Jeffrey J Wine, Jeeyeon Kim, Miesha Farahmand, Colleen Dunn, Zoe Davies, Eric Frisbee, Carlos Milla, Jeffrey J Wine
Abstract
Beta-adrenergically-stimulated sweat rates determined by evaporimetry or by sweat bubble imaging are useful for measuring CFTR function because they provide a near-linear readout across almost the full range of CFTR function. They differentiate cystic fibrosis (CF) subjects from CF carriers and carriers from controls. However, evaporimetry, unlike bubble imaging, appears to be unable to detect improved levels of CFTR function in G551D subjects taking the CFTR modulator ivacaftor. Here, we quantify the sensitivity of evaporimetry and bubble imaging methods for assessing low levels of CFTR-dependent sweat rates. To establish sensitivity, we did dose-ranging studies using intradermally injected [cAMP]i-elevating cocktails. We reduced isoproterenol/aminophylline levels while maintaining a high level of atropine to block muscarinic elevation of [Ca2+]i. We stimulated the same sets of glands for both assays and recorded responses for 20 min. In response to a 3-log dilution of the stimulating cocktail (0.1%), bubble responses were detected in 12/12 tests (100%), with 49% ± 3% of glands secreting to produce an aggregate volume of 598 nl across the 12, 20-min tests. This was ~5% of the response to full cocktail. Evaporimetry detected responses in 3/12 (25%) tests with an aggregate secretion volume of 175 nl. After stimulation with a still more dilute cocktail (0.03%), bubble imaging detected 15 ± 13% of glands secreting at a rate ~0.9% of the response to full cocktail, while zero responding was seen with evaporimetry. The bubble imaging method detected secretion down to aggregate rates of <0.2 nl/(cm2·min), or ~1/30th of the average basal transepithelial water loss (TEWL) in the test subject of 4 g/m2·hr or 6.7 nl/(cm2·min). The increased sensitivity of bubble imaging may be required to detect small but physiologically important increases in secretion rates produced by CFTR modulators.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066–73. .
- Quinton PM. Cystic fibrosis: lessons from the sweat gland. Physiology. 2007;22:212–25. Epub 2007/06/15. 10.1152/physiol.00041.2006 .
- Di Sant'Agnese P, Darling RC, Perara GA, Shea E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. AMA Am J Dis Child. 1953;86(5):618–9; discussion, 9. Epub 1953/11/01. .
- Accurso FJ, Van Goor F, Zha J, Stone AJ, Dong Q, Ordonez CL, et al. Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data. J Cyst Fibros. 2014;13(2):139–47. .
- Collaco JM, Blackman SM, Raraigh KS, Corvol H, Rommens JM, Pace RG, et al. Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis. American journal of respiratory and critical care medicine. 2016. 10.1164/rccm.201603-0459OC .
- Char JE, Wolfe MH, Cho HJ, Park IH, Jeong JH, Frisbee E, et al. A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor. PLoS ONE. 2014;9(2):e88564 Epub 2014/02/13. 10.1371/journal.pone.0088564 PONE-D-13-49924 [pii].
- Wilschanski M, Dupuis A, Ellis L, Jarvi K, Zielenski J, Tullis E, et al. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. American journal of respiratory and critical care medicine. 2006;174(7):787–94. 10.1164/rccm.200509-1377OC
- Sato K, Sato F. Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro. Journal of Clinical Investigation. 1984;73(6):1763–71. 10.1172/JCI111385
- Behm JK, Hagiwara G, Lewiston NJ, Quinton PM, Wine JJ. Hyposecretion of beta-adrenergically induced sweating in cystic fibrosis heterozygotes. Pediatric research. 1987;22(3):271–6. Epub 1987/09/01. 10.1203/00006450-198709000-00007 .
- Wine JJ, Char JE, Chen J, Cho HJ, Dunn C, Frisbee E, et al. In Vivo Readout of CFTR Function: Ratiometric Measurement of CFTR-Dependent Secretion by Individual, Identifiable Human Sweat Glands. PLoS ONE. 2013;8(10):e77114 Epub 2013/11/10. 10.1371/journal.pone.0077114 PONE-D-13-25271 [pii].
- Quinton P, Molyneux L, Ip W, Dupuis A, Avolio J, Tullis E, et al. beta-adrenergic sweat secretion as a diagnostic test for cystic fibrosis. American journal of respiratory and critical care medicine. 2012;186(8):732–9. Epub 2012/08/04. 10.1164/rccm.201205-0922OC rccm.201205-0922OC [pii]. .
- Shamsuddin AK, Reddy MM, Quinton PM. Iontophoretic beta-adrenergic stimulation of human sweat glands: possible assay for cystic fibrosis transmembrane conductance regulator activity in vivo. Experimental physiology. 2008;93(8):969–81. Epub 2008/04/29. 10.1113/expphysiol.2008.042283 .
- Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. The New England journal of medicine. 2010;363(21):1991–2003. Epub 2010/11/19. 10.1056/NEJMoa0909825 .
- Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Drevinek P, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. The New England journal of medicine. 2011;365(18):1663–72. Epub 2011/11/04. 10.1056/NEJMoa1105185.
- Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, et al. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. The New England journal of medicine. 2015. 10.1056/NEJMoa1409547 .
- Pinnagoda J, Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis. 1990;22(3):164–78. Epub 1990/03/01. .
- Pinnagoda J, Tupker RA, Coenraads PJ, Nater JP. Transepidermal water loss with and without sweat gland inactivation. Contact Dermatitis. 1989;21(1):16–22. Epub 1989/07/01. .
- Kuno Y. Human Perspiration. Springfield IL: Thomas; 1956.
- Reddy MM, Quinton PM. Electrophysiologically distinct cell types in human sweat gland secretory coil. The American journal of physiology. 1992;262(2 Pt 1):C287–92. Epub 1992/02/01. .
Source: PubMed